Carol Morris
Developing a Therapeutic for Faster Stroke Treatment
Project Highlights
For every minute that a patient goes untreated after having a stroke, they lose an average of 1.9 million neurons. The lack of blood flow to the brain deprives brain cells of oxygen, causing irreversible damage. Carol Morris is developing a multi-use therapeutic that can be delivered to patients faster after stroke.
I am honored to receive one of PhRMA Foundation's 2024 predoctoral fellowships. Ischemic stroke is a major cause of death and morbidity worldwide. This award has emboldened my mission to develop a novel therapeutic to treat this condition and contribute to the field. Furthermore, this grant will assist me with obtaining the necessary training to reach my future goals as a neuroscientist.